Shandong Xinhua Pharmaceutical Company Limited Class H (XIN) Stock Statistics & Valuation Metrics

Shandong Xinhua Pharmaceutical Company Limited Class H has a market cap or net worth of EUR 941.24M. The enterprise value is EUR 4.99B.

Market Cap

EUR 941.24M

Enterprise Value

EUR 4.99B

Shandong Xinhua Pharmaceutical Company Limited Class H has 195,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

195,000,000

Owned by Insiders

―

Owned by Institutions

1.94%

Shandong Xinhua Pharmaceutical Company Limited Class H’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.03%.

Return on Equity (ROE)

0.06

Return on Assets (ROA)

0.03

Return on Invested Capital (ROIC)

4.03%

Return on Capital Employed (ROCE)

0.06

Revenue Per Employee

1.21M

Profits Per Employee

40.04K

Employee Count

7,240

Asset Turnover

0.95

Inventory Turnover

5.39

The current PE Ratio of Shandong Xinhua Pharmaceutical Company Limited Class H is 37.23. Shandong Xinhua Pharmaceutical Company Limited Class H’s PEG ratio is -0.96.

PE Ratio

37.23

PS Ratio

0.76

PB Ratio

1.60

Price to FCF

19.76

Price to Operating Cash Flow

21.67

PEG Ratio

-0.96

In the last 12 months, Shandong Xinhua Pharmaceutical Company Limited Class H had revenue of 8.75B and earned 289.89M in profits. Earnings per share was 0.42.

Revenue

8.75B

Gross Profit

1.64B

Operating Income

363.98M

Pretax Income

358.92M

Net Income

289.89M

EBITDA

988.87M

Earnings Per Share (EPS)

0.42

In the last 12 months, operating cash flow was 390.87M and capital expenditures -83.07M, giving a free cash flow of 307.79M billion.

Operating Cash Flow

390.87M

Free Cash Flow

307.79M

Free Cash Flow per Share

0.45

Shandong Xinhua Pharmaceutical Company Limited Class H pays an annual dividend of ―, resulting in a dividend yield of 3.18%

Dividend Per Share

―

Dividend Yield

3.18%

Payout Ratio

N/A

Free Cash Flow Yield

5.06%

Earnings Yield

2.68%

Beta

0.16

52-Week Price Change

-21.09%

50-Day Moving Average

0.60

200-Day Moving Average

0.64

Relative Strength Index (RSI)

42.20

Average Volume (3m)

―

Shandong Xinhua Pharmaceutical Company Limited Class H upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 28, 2026

Next Earnings Date

Mar 31, 2027

Ex-Dividend Date

―

Shandong Xinhua Pharmaceutical Company Limited Class H as a current ratio of 1.43, with Debt / Equity ratio of 25.19%

Current Ratio

1.43

Quick Ratio

0.97

Debt to Market Cap

0.50

Net Debt to EBITDA

-0.09

Interest Coverage Ratio

8.40

In the past 12 months, Shandong Xinhua Pharmaceutical Company Limited Class H has paid 52.61M in taxes.

Income Tax

52.61M

Effective Tax Rate

0.15

Shandong Xinhua Pharmaceutical Company Limited Class H EV to EBITDA ratio is 14.68, with an EV/FCF ratio of 21.57.

EV to Sales

0.83

EV to EBITDA

14.68

EV to Free Cash Flow

21.57

EV to Operating Cash Flow

17.03

Shandong Xinhua Pharmaceutical Company Limited Class H has EUR 1.19B in cash and marketable securities with EUR 894.24M in debt, giving a net cash position of EUR 300.61M billion.

Cash & Marketable Securities

EUR 1.19B

Total Debt

EUR 894.24M

Net Cash

EUR 300.61M

Net Cash Per Share

EUR 1.54

Tangible Book Value Per Share

EUR 7.23

Gross margin is 17.87%, with operating margin of 3.61%, and net profit margin of 2.84%.

Gross Margin

17.87%

Operating Margin

3.61%

Pretax Margin

3.30%

Net Profit Margin

2.84%

EBITDA Margin

5.67%

EBIT Margin

3.77%

The average price target for Shandong Xinhua Pharmaceutical Company Limited Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-5.81%

EPS Growth Forecast

-41.87%

Smart Score

2

AI Score

―